Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review.
Syrowatka A, Song W, Amato MG, Foer D, Edrees H, Co Z, Kuznetsova M, Dulgarian S, Seger DL, Simona A, Bain PA, Purcell Jackson G, Rhee K, Bates DW.
Syrowatka A, et al. Among authors: bates dw.
Lancet Digit Health. 2022 Feb;4(2):e137-e148. doi: 10.1016/S2589-7500(21)00229-6. Epub 2021 Nov 23.
Lancet Digit Health. 2022.
PMID: 34836823
Free article.
Review.